Replimune Group, Inc. (REPL) Misses Q2 EPS by 5c

Replimune Group, Inc. (NASDAQ: REPL) reported Q2 EPS of ($0.79), $0.05 worse than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• Morgan Stanley cautious on Coinbase, but target implies over 40% upside
• Driven Brands (DRVN) PT Raised to $18 at Canaccord